𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O6-benzylguanine and BCNU in multiple myeloma: a phase II trial

✍ Scribed by Eric D. Batts; Christopher Maisel; Donna Kane; Lili Liu; Pingfu Fu; Timothy O’Brien; Scot Remick; Nizar Bahlis; Stanton L. Gerson

Book ID
105992599
Publisher
Springer
Year
2007
Tongue
English
Weight
250 KB
Volume
60
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of amsacrine in patients
Phase II trial of amsacrine in patients with multiple myeloma
✍ Greipp, Philip R. ;Coleman, Morton ;Anderson, Keaven ;McIntyre, O. Ross 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

Seventy-four previously treated patients with multiple myeloma were treated with Amsacrine (m-AMSA) 120 mg/m2 every 3 weeks. A good response was observed in two patients (3%), and improvement was seen in three patients (4%). Severe toxicity was observed in 33% of patients who received three or more

A phase II trial of didemnin B in myelom
A phase II trial of didemnin B in myeloma
✍ Raymond B. Weiss; Bercedis L. Peterson; Steven L. Allen; Scott M. Browning; Davi 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 272 KB